Back
Y-mAbs Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
YMAB
Y-mAbs Therapeutics
Last Price:
$4.33
Seasonality Move:
-4.07%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and YMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Y-mAbs Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.34 | Buy |
| 20-day SMA: | 4.51 | Sell |
| 50-day SMA: | 4.47 | Sell |
| 200-day SMA: | 7.54 | Sell |
| 8-day EMA: | 3.59 | Buy |
| 20-day EMA: | 2.19 | Buy |
| 50-day EMA: | 1.06 | Buy |
| 200-day EMA: | 0.29 | Buy |
Y-mAbs Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 46.01 | Sell |
| Chaikin Money Flow: | 105197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.3 - 4.86) | Sell |
| Bollinger Bands (100): | (4.17 - 5.13) | Sell |
Y-mAbs Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Y-mAbs Therapeutics Stock
Is Y-mAbs Therapeutics Stock a Buy?
-
Y-mAbs Therapeutics share price is 4.35 while YMAB 8-day simple moving average is 4.34, which is a Buy signal.
-
The stock price of YMAB is 4.35 while Y-mAbs Therapeutics 20-day SMA is 4.51, which makes it a Sell.
-
Y-mAbs Therapeutics 50-day simple moving average is 4.47 while YMAB share price is 4.35, making it a Sell technically.
-
YMAB stock price is 4.35 and Y-mAbs Therapeutics 200-day simple moving average is 7.54, creating a Sell signal.
YMAB Technical Analysis vs Fundamental Analysis
Sell
34
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy or a Sell?
-
Y-mAbs Therapeutics stock is rated a SellThe current Y-mAbs Therapeutics [YMAB] share price is $4.35. The Score for YMAB is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Y-mAbs Therapeutics Stock Info
Market Cap:
197M
Price in USD:
4.35
Share Volume:
181.7K
Y-mAbs Therapeutics 52-Week Range
52-Week High:
16.11
52-Week Low:
3.55
Sell
34
Y-mAbs Therapeutics (YMAB)
is a Sell
Y-mAbs Therapeutics Share Price Forecast
-
What is the Y-mAbs Therapeutics stock price today?The Y-mAbs Therapeutics stock price is 4.35 USD today.
-
Will YMAB stock go up or go down?Y-mAbs Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Y-mAbs Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Y-mAbs Therapeutics is overvalued.
Is Y-mAbs Therapeutics Stock a Buy?
-
Y-mAbs Therapeutics share price is 4.35 while YMAB 8-day exponential moving average is 3.59, which is a Buy signal.
-
The stock price of YMAB is 4.35 while Y-mAbs Therapeutics 20-day EMA is 2.19, which makes it a Buy.
-
Y-mAbs Therapeutics 50-day exponential moving average is 1.06 while YMAB share price is 4.35, making it a Buy technically.
-
YMAB stock price is 4.35 and Y-mAbs Therapeutics 200-day simple moving average is 0.29, creating a Buy signal.
Fundamental Analysis of Y-mAbs Therapeutics
Is Y-mAbs Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Y-mAbs Therapeutics
Should I short Y-mAbs Therapeutics stock?
-
YMAB Moving Average Covergence Divergence (MACD) indicator is 1.18, suggesting Y-mAbs Therapeutics is a Buy
-
Y-mAbs Therapeutics Relative Strength Index (RSI) is 46.01, which suggest Y-mAbs Therapeutics is oversold
-
The Bollinger Bands (25) for Y-mAbs Therapeutics is (4.3 - 4.86), which suggest Y-mAbs Therapeutics is a Sell
-
The Bollinger Bands (100) for Y-mAbs Therapeutics is (4.17 - 5.13), which suggest Y-mAbs Therapeutics is a Sell
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.